Zydus Lifesciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported revenue was INR 45,429 million compared to INR 42,956 million a year ago. Net income was INR 7,896 million compared to INR 6,229 million a year ago. Basic earnings per share from continuing operations was INR 7.59 compared to INR 6.15 a year ago. Diluted earnings per share from continuing operations was INR 7.59 compared to INR 6.15 a year ago. Basic earnings per share was INR 7.8 compared to INR 6.15 a year ago. Diluted earnings per share was INR 7.8 compared to INR 6.15 a year ago.
For the nine months, revenue was INR 141,413 million compared to INR 123,757 million a year ago. Net income was INR 26,772 million compared to INR 16,637 million a year ago. Basic earnings per share from continuing operations was INR 26.25 compared to INR 16.39 a year ago. Diluted earnings per share from continuing operations was INR 26.25 compared to INR 16.39 a year ago. Basic earnings per share was INR 26.45 compared to INR 16.36 a year ago. Diluted earnings per share was INR 26.45 compared to INR 16.36 a year ago.